Jw Holdings (096760) - Total Liabilities
Based on the latest financial reports, Jw Holdings (096760) has total liabilities worth ₩662.18 Billion KRW (≈ $448.75 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Jw Holdings to see how much of total assets are deployed in long-term investments.
Jw Holdings - Total Liabilities Trend (2007–2024)
This chart illustrates how Jw Holdings's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 096760 total assets.
Jw Holdings Competitors by Total Liabilities
The table below lists competitors of Jw Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Scicom MSC Bhd
KLSE:0099
|
Malaysia | RM43.59 Million |
|
Guolian Securities Co. Ltd
F:34V
|
Germany | €133.81 Billion |
|
Doosan Co Ltd
KO:000157
|
Korea | ₩20.11 Trillion |
|
AGILYX ASA NK -02
F:5NQ
|
Germany | €76.24 Million |
|
RCI Hospitality Holdings Inc
NASDAQ:RICK
|
USA | $328.11 Million |
|
NRC Group ASA
OL:NRC
|
Norway | Nkr2.91 Billion |
|
Onward Medical N.V.
BR:ONWD
|
Belgium | €29.24 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down Jw Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Jw Holdings's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Holdings (2007–2024)
The table below shows the annual total liabilities of Jw Holdings from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩729.21 Billion ≈ $494.18 Million |
-11.88% |
| 2023-12-31 | ₩827.51 Billion ≈ $560.79 Million |
+0.39% |
| 2022-12-31 | ₩824.32 Billion ≈ $558.63 Million |
+8.33% |
| 2021-12-31 | ₩760.96 Billion ≈ $515.69 Million |
-2.91% |
| 2020-12-31 | ₩783.76 Billion ≈ $531.14 Million |
-12.12% |
| 2019-12-31 | ₩891.84 Billion ≈ $604.39 Million |
+1.97% |
| 2018-12-31 | ₩874.64 Billion ≈ $592.73 Million |
-10.44% |
| 2017-12-31 | ₩976.65 Billion ≈ $661.86 Million |
+6.27% |
| 2016-12-31 | ₩919.04 Billion ≈ $622.82 Million |
+13.10% |
| 2015-12-31 | ₩812.56 Billion ≈ $550.66 Million |
-1.40% |
| 2014-12-31 | ₩824.06 Billion ≈ $558.46 Million |
+5.86% |
| 2013-12-31 | ₩778.42 Billion ≈ $527.52 Million |
-10.70% |
| 2012-12-31 | ₩871.67 Billion ≈ $590.72 Million |
+2.77% |
| 2011-12-31 | ₩848.16 Billion ≈ $574.79 Million |
+55.79% |
| 2010-12-31 | ₩544.41 Billion ≈ $368.94 Million |
+11.28% |
| 2009-12-31 | ₩489.21 Billion ≈ $331.53 Million |
+14.27% |
| 2008-12-31 | ₩428.10 Billion ≈ $290.12 Million |
+25.85% |
| 2007-12-31 | ₩340.17 Billion ≈ $230.53 Million |
-- |
About Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more